Kura Oncology Inc and The Regents of the Univ of Michigan Granted United States Patent for Bridged Bicyclic Inhibitors of Menin-Mll and Methods of Use

Press/Media: Press / Media

PeriodJan 23 2023

Media coverage

1

Media coverage

  • TitleKura Oncology Inc and The Regents of the Univ of Michigan Granted United States Patent for Bridged Bicyclic Inhibitors of Menin-Mll and Methods of Use
    Media name/outletGlobal IP News. Biotechnology Patent News
    Country/TerritoryIndia
    Date1/23/23
    PersonsYi Ren